HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients

BACKGROUND: To evaluate the diagnostic value of adding human epididymis protein 4 (HE4), cancer antigen 125 (CA125) and risk of malignancy algorithm (ROMA) to ultrasound for detecting ovarian cancer in patients with a pelvic mass. METHODS: This was a prospective, observational, multicenter study. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Braicu, Elena Ioana, Krause, Catherine Linn, Torsten, Uwe, Mecke, Herbert, Richter, Rolf, Hellmeyer, Lars, Lanowska, Malgorzata, Müller, Bodo, Koch, Elisa, Boenneß-Zaloum, Janine, Ames, Kerstin, Chekerov, Radoslav, Hasenbein, Kati, Zimmermann, Mathias, Mangler, Mandy, Chen, Frank, Tauber, Rudolf, Sehouli, Jalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338568/
https://www.ncbi.nlm.nih.gov/pubmed/35907794
http://dx.doi.org/10.1186/s12885-022-09887-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338568/
https://www.ncbi.nlm.nih.gov/pubmed/35907794
http://dx.doi.org/10.1186/s12885-022-09887-5

Ejemplares similares